Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT04332588

1 development in the corpus

NCT04332588

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 17, 2026 · PHASE 1 TRIAL

Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI

ClinicalTrials.gov

Phase 1 interventional imaging study with no posted results; designed to evaluate feasibility and imaging biomarkers in a small cohort, not yet powered to support clinical decisions.

PreliminaryHER2 Positive Breast Cancer NCT04332588 [18F]FMISO PET/MRI imaging

Reported

Planned enrollment25

Study phasePhase 1

Primary outcome measure 1Baseline PET standardized uptake value (SUV)

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support